{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:12:54Z","timestamp":1785510774743,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515011451"],"award-info":[{"award-number":["2024A1515011451"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Li Xin Traditional Chinese Medicine Research and Innovation Fund","award":["2023-CCA-TCM-033"],"award-info":[{"award-number":["2023-CCA-TCM-033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05221-z","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:58:07Z","timestamp":1774241887000},"page":"13221-13232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dapagliflozin attenuates myocardial fibrosis after myocardial infarction through regulating Lnc-Ang362\/miR-200b-3p"],"prefix":"10.1007","volume":"399","author":[{"given":"Xueqian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa Ide","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"18","key":"5221_CR1","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/01.CIR.0000036014.90197.FA","volume":"106","author":"L Bolognese","year":"2002","unstructured":"Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D (2002) Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106(18):2351\u20132357","journal-title":"Circulation"},{"issue":"7","key":"5221_CR2","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00204-022-03298-y","volume":"96","author":"WT Chang","year":"2022","unstructured":"Chang WT, Shih JY, Lin YW, Chen ZC, Kan WC, Lin TH, Hong CS (2022) Dapagliflozin protects against doxorubicin-induced cardiotoxicity by restoring STAT3. Arch Toxicol 96(7):2021\u20132032","journal-title":"Arch Toxicol"},{"issue":"9","key":"5221_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1089\/dna.2017.3725","volume":"36","author":"W Chen","year":"2017","unstructured":"Chen W, Zhu H, Yin L, Wang T, Wu J, Xu J et al (2017a) LncRNA-PVT1 facilitates invasion through upregulation of MMP9 in nonsmall cell lung cancer cell. DNA Cell Biol 36(9):787\u2013793","journal-title":"DNA Cell Biol"},{"issue":"8","key":"5221_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.421","volume":"8","author":"DL Chen","year":"2017","unstructured":"Chen DL, Chen LZ, Lu YX, Zhang DS, Zeng ZL, Pan ZZ et al (2017b) Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer. Cell Death Dis 8(8):e3011","journal-title":"Cell Death Dis"},{"key":"5221_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108354","volume":"685","author":"G Chen","year":"2020","unstructured":"Chen G, Huang S, Song F, Zhou Y, He X (2020) Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7. Arch Biochem Biophys 685:108354","journal-title":"Arch Biochem Biophys"},{"key":"5221_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.873108","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Yang Q, Bai W, Yao W, Liu L, Xing Y et al (2022) Dapagliflozin attenuates myocardial fibrosis by inhibiting the TGF-beta1\/Smad signaling pathway in a normoglycemic rabbit model of chronic heart failure. Front Pharmacol 13:873108","journal-title":"Front Pharmacol"},{"issue":"6","key":"5221_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/sj.gt.3303071","volume":"15","author":"A Dandapat","year":"2008","unstructured":"Dandapat A, Hu CP, Li D, Liu Y, Chen H, Hermonat PL, Mehta JL (2008) Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury. Gene Ther 15(6):415\u2013423","journal-title":"Gene Ther"},{"key":"5221_CR8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2147\/DDDT.S371506","volume":"16","author":"ZG Fan","year":"2022","unstructured":"Fan ZG, Xu Y, Chen X, Ji MY, Ma GS (2022) Appropriate dose of dapagliflozin improves cardiac outcomes by normalizing mitochondrial fission and reducing cardiomyocyte apoptosis after acute myocardial infarction. Drug des Devel Ther 16:2017\u20132030","journal-title":"Drug des Devel Ther"},{"issue":"3","key":"5221_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.2337\/db15-1033","volume":"65","author":"B Feng","year":"2016","unstructured":"Feng B, Cao Y, Chen S, Chu X, Chu Y, Chakrabarti S (2016) MiR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy. Diabetes 65(3):768\u2013779","journal-title":"Diabetes"},{"issue":"12","key":"5221_CR10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1080\/17425255.2018.1551877","volume":"14","author":"A Garcia-Ropero","year":"2018","unstructured":"Garcia-Ropero A, Badimon JJ, Santos-Gallego CG (2018) The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments. Expert Opin Drug Metab Toxicol 14(12):1287\u20131302","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"5221_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.119.042474","volume":"141","author":"CPC Gomes","year":"2020","unstructured":"Gomes CPC, Schroen B, Kuster GM, Robinson EL, Ford K, Squire IB et al (2020) Regulatory RNAs in heart failure. Circulation 141(4):313\u2013328","journal-title":"Circulation"},{"issue":"1","key":"5221_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.CIR.0000074225.62168.68","volume":"108","author":"K Hayakawa","year":"2003","unstructured":"Hayakawa K, Takemura G, Kanoh M, Li Y, Koda M, Kawase Y et al (2003) Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 108(1):104\u2013109","journal-title":"Circulation"},{"issue":"10","key":"5221_CR13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00380-016-0808-z","volume":"31","author":"X He","year":"2016","unstructured":"He X, Zhang K, Gao X, Li L, Tan H, Chen J, Zhou Y (2016) Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessels 31(10):1696\u20131708","journal-title":"Heart Vessels"},{"key":"5221_CR14","doi-asserted-by":"crossref","unstructured":"Hsieh PL, Chu PM, Cheng HC, Huang YT, Chou WC, Tsai KL, Chan SH (2022) Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation. Int J Mol Sci 23(17)","DOI":"10.3390\/ijms231710146"},{"issue":"12","key":"5221_CR15","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1111\/jcmm.13866","volume":"22","author":"Y Huang","year":"2018","unstructured":"Huang Y (2018) The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med 22(12):5768\u20135775","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5221_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0549-2","volume":"111","author":"J Jose Corbalan","year":"2016","unstructured":"Jose Corbalan J, Vatner DE, Vatner SF (2016) Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol 111(3):31","journal-title":"Basic Res Cardiol"},{"issue":"22","key":"5221_CR17","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1161\/CIRCULATIONAHA.119.040130","volume":"139","author":"ET Kato","year":"2019","unstructured":"Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM et al (2019) Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus. Circulation 139(22):2528\u20132536","journal-title":"Circulation"},{"issue":"3","key":"5221_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"M Kosiborod","year":"2017","unstructured":"Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW et al (2017) Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors). Circulation 136(3):249\u2013259","journal-title":"Circulation"},{"key":"5221_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","volume":"104","author":"TM Lee","year":"2017","unstructured":"Lee TM, Chang NC, Lin SZ (2017) Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic Biol Med 104:298\u2013310","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5221_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.7150\/thno.23364","volume":"8","author":"MS Leisegang","year":"2018","unstructured":"Leisegang MS (2018) LET\u2019s sponge: how the lncRNA PFL promotes cardiac fibrosis. Theranostics 8(4):874\u2013877","journal-title":"Theranostics"},{"issue":"3","key":"5221_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.112.300849","volume":"113","author":"A Leung","year":"2013","unstructured":"Leung A, Trac C, Jin W, Lanting L, Akbany A, Saetrom P et al (2013) Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 113(3):266\u2013278","journal-title":"Circ Res"},{"issue":"1","key":"5221_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X et al (2019) SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol 18(1):15","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"5221_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"24","key":"5221_CR24","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.7150\/thno.32637","volume":"9","author":"K Lv","year":"2019","unstructured":"Lv K, Li Q, Zhang L, Wang Y, Zhong Z, Zhao J et al (2019) Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction. Theranostics 9(24):7403\u20137416","journal-title":"Theranostics"},{"issue":"5","key":"5221_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ejhf.1432","volume":"21","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, DeMets DL, Inzucchi SE, Kober L, Kosiborod MN, Langkilde AM et al (2019a) A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail 21(5):665\u2013675","journal-title":"Eur J Heart Fail"},{"issue":"21","key":"5221_CR26","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA et al (2019b) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"key":"5221_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai9118","author":"R Micheletti","year":"2017","unstructured":"Micheletti R, Plaisance I, Abraham BJ, Sarre A, Ting CC, Alexanian M et al (2017) The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aai9118","journal-title":"Sci Transl Med"},{"issue":"5","key":"5221_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","volume":"121","author":"MT Piccoli","year":"2017","unstructured":"Piccoli MT, Gupta SK, Viereck J, Foinquinos A, Samolovac S, Kramer FL et al (2017) Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res 121(5):575\u2013583","journal-title":"Circ Res"},{"issue":"1","key":"5221_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119(1):91\u2013112","journal-title":"Circ Res"},{"issue":"2","key":"5221_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jcmg.2020.07.042","volume":"14","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Garcia-Ropero A, Ishikawa K, Watanabe S et al (2021) Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis\/stiffness in nondiabetic heart failure: a multimodality study. JACC Cardiovasc Imaging 14(2):393\u2013407","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"5221_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G et al (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun 11(1):163","journal-title":"Nat Commun"},{"issue":"5","key":"5221_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/ajh\/hpz016","volume":"32","author":"L Shi","year":"2019","unstructured":"Shi L, Zhu D, Wang S, Jiang A, Li F (2019) Dapagliflozin attenuates cardiac remodeling in mice model of cardiac pressure overload. Am J Hypertens 32(5):452\u2013459","journal-title":"Am J Hypertens"},{"issue":"25","key":"5221_CR33","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101(25):2981\u20132988","journal-title":"Circulation"},{"issue":"10","key":"5221_CR34","doi-asserted-by":"publisher","first-page":"F1266","DOI":"10.1152\/ajprenal.00302.2012","volume":"304","author":"O Tang","year":"2013","unstructured":"Tang O, Chen XM, Shen S, Hahn M, Pollock CA (2013) MiRNA-200b represses transforming growth factor-beta1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am J Physiol Renal Physiol 304(10):F1266\u2013F1273","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"5221_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00424-016-1792-y","volume":"468","author":"H Tao","year":"2016","unstructured":"Tao H, Yang JJ, Hu W, Shi KH, Deng ZY, Li J (2016) Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead. Pflugers Arch 468(6):1103\u20131111","journal-title":"Pflugers Arch"},{"issue":"16","key":"5221_CR36","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1111\/jcmm.16601","volume":"25","author":"J Tian","year":"2021","unstructured":"Tian J, Zhang M, Suo M, Liu D, Wang X, Liu M et al (2021) Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKalpha\/TGF-beta\/Smad signalling in type 2 diabetic rats. J Cell Mol Med 25(16):7642\u20137659","journal-title":"J Cell Mol Med"},{"issue":"5","key":"5221_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2018.05.038","volume":"72","author":"N Uriel","year":"2018","unstructured":"Uriel N, Sayer G, Annamalai S, Kapur NK, Burkhoff D (2018) Mechanical unloading in heart failure. J Am Coll Cardiol 72(5):569\u2013580","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5221_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","volume":"7","author":"SW van den Borne","year":"2010","unstructured":"van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7(1):30\u201337","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"5221_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024330","volume":"11","author":"J Wan","year":"2022","unstructured":"Wan J, Lin S, Yu Z, Song Z, Lin X, Xu R, Du S (2022) Protective effects of MicroRNA-200b-3p encapsulated by mesenchymal stem cells-secreted extracellular vesicles in myocardial infarction via regulating BCL2L11. J Am Heart Assoc 11(12):e024330","journal-title":"J Am Heart Assoc"},{"issue":"1\u20132","key":"5221_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mce.2014.05.018","volume":"392","author":"JY Wang","year":"2014","unstructured":"Wang JY, Gao YB, Zhang N, Zou DW, Wang P, Zhu ZY et al (2014) MiR-21 overexpression enhances TGF-beta1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol 392(1\u20132):163\u2013172","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"5221_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/SHK.0000000000001410","volume":"53","author":"H Wang","year":"2020","unstructured":"Wang H, Qin R, Cheng Y (2020) LncRNA-Ang362 promotes pulmonary arterial hypertension by regulating miR-221 and miR-222. Shock 53(6):723\u2013729","journal-title":"Shock"},{"issue":"4","key":"5221_CR42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s12265-021-10192-y","volume":"15","author":"K Wang","year":"2022","unstructured":"Wang K, Li Z, Sun Y, Liu X, Ma W, Ding Y et al (2022) Dapagliflozin improves cardiac function, remodeling, myocardial apoptosis, and inflammatory cytokines in mice with myocardial infarction. J Cardiovasc Transl Res 15(4):786\u2013796","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"5221_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jshs.2020.11.010","volume":"10","author":"Y Xi","year":"2021","unstructured":"Xi Y, Hao M, Liang Q, Li Y, Gong DW, Tian Z (2021) Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2\/3 in rats following myocardial infarction. J Sport Health Sci 10(5):594\u2013603","journal-title":"J Sport Health Sci"},{"issue":"4","key":"5221_CR44","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1002\/jcb.27795","volume":"120","author":"L Xu","year":"2019","unstructured":"Xu L, Chen W, Ma M, Chen A, Tang C, Zhang C, Cai L (2019) Microarray profiling analysis identifies the mechanism of miR-200b-3p\/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-gamma signaling pathway. J Cell Biochem 120(4):5193\u20135206","journal-title":"J Cell Biochem"},{"issue":"2","key":"5221_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajpath.2011.10.005","volume":"180","author":"S Yang","year":"2012","unstructured":"Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S et al (2012) Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180(2):484\u2013493","journal-title":"Am J Pathol"},{"issue":"10","key":"5221_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Qin Y, Lv J, Wang Y, Che H, Chen X et al (2018) Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis 9(10):1000","journal-title":"Cell Death Dis"},{"issue":"10254","key":"5221_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","volume":"396","author":"F Zannad","year":"2020","unstructured":"Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G et al (2020) SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet 396(10254):819\u2013829","journal-title":"Lancet"},{"issue":"1","key":"5221_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-021-01312-8","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Lin X, Chu Y, Chen X, Du H, Zhang H et al (2021a) Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFbeta1\/Smad signaling. Cardiovasc Diabetol 20(1):121","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5221_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12872-021-01980-0","volume":"21","author":"F Zhang","year":"2021","unstructured":"Zhang F, Cheng N, Du J, Zhang H, Zhang C (2021b) MicroRNA-200b-3p promotes endothelial cell apoptosis by targeting HDAC4 in atherosclerosis. BMC Cardiovasc Disord 21(1):172","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"5221_CR50","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1523\/JNEUROSCI.22-10-03898.2002","volume":"22","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C et al (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22(10):3898\u20133909","journal-title":"J Neurosci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05221-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:43:26Z","timestamp":1783914206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05221-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5221"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05221-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Ethics Committee for Animal Experimentation at Guangdong Provincial People's Hospital of Guangdong Academy of Medical Sciences (Approval No: KY2020-491\u201301, Title: Study on the Role and Mechanism of Exosome Lnc-Ang362 in Mediating Communication between Cardiomyocytes and Fibroblasts to Promote Cardiac Fibrosis), initially granted in August,08,2020. The use of animals was justified based on the need to assess safety, biocompatibility, and MI efficacy of the tested formulations in an in vivo setting, which cannot be adequately replicated in vitro.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}